Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  Y. Osawa,et al.  An NA-deficient 2009 pandemic H1N1 influenza virus mutant can efficiently replicate in cultured cells , 2014, Archives of Virology.

[3]  K. Awazu,et al.  Evaluation of Anti-A/Udorn/307/1972 Antibody Specificity to Influenza A/H3N2 Viruses Using an Evanescent-Field Coupled Waveguide-Mode Sensor , 2013, PloS one.

[4]  A. Mira,et al.  Microbial Geography of the Oral Cavity , 2013, Journal of dental research.

[5]  T. Takayama,et al.  Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor , 2012, PloS one.

[6]  P. Horby,et al.  Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.

[7]  M. Oyama,et al.  F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding , 2012, Proceedings of the National Academy of Sciences.

[8]  K. Ochiai,et al.  The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification. , 2012, Biochimie.

[9]  T. Okamoto,et al.  Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria , 2012, Cellular and Molecular Life Sciences.

[10]  M. Wise,et al.  Influenza-related pneumonia. , 2012, Clinical medicine.

[11]  E. Vermeire,et al.  A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. , 2011, Vaccine.

[12]  S. Hassan,et al.  Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection , 2011, Virology Journal.

[13]  Lucio Lo Russo,et al.  Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. , 2010, European journal of internal medicine.

[14]  H. Nagamune,et al.  Sialidase of Streptococcus intermedius: a putative virulence factor modifying sugar chains , 2010, Microbiology and immunology.

[15]  M. Hedlund,et al.  Antiviral Strategies for Pandemic and Seasonal Influenza , 2010, Viruses.

[16]  Masato Tashiro,et al.  Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer , 2010, PloS one.

[17]  Robert Schechter,et al.  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.

[18]  T. Okamoto,et al.  Reactivation of Latent HIV-1 Infection by the Periodontopathic Bacterium Porphyromonas gingivalis Involves Histone Modification1 , 2009, The Journal of Immunology.

[19]  Larisa V. Gubareva,et al.  Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008 , 2008, Antimicrobial Agents and Chemotherapy.

[20]  K. Hirota,et al.  Professional oral health care reduces the number of oropharyngeal bacteria , 2008, BDJ.

[21]  K. Okuda,et al.  Professional oral health care by dental hygienists reduced respiratory infections in elderly persons requiring nursing care. , 2007, International journal of dental hygiene.

[22]  J. A. Aas,et al.  The breadth of bacterial diversity in the human periodontal pocket and other oral sites. , 2006, Periodontology 2000.

[23]  Amir Azarpazhooh,et al.  Systematic review of the association between respiratory diseases and oral health , 2006, Journal of periodontology.

[24]  K. Okuda,et al.  Professional oral care reduces influenza infection in elderly. , 2006, Archives of gerontology and geriatrics.

[25]  J. McCullers.  Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[26]  J. A. Aas,et al.  Defining the Normal Bacterial Flora of the Oral Cavity , 2005, Journal of Clinical Microbiology.

[27]  T. Attin,et al.  Enzymes in the acquired enamel pellicle. , 2005, European journal of oral sciences.

[28]  L. Shapira,et al.  Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function , 2003, Nature Immunology.

[29]  N. Cox,et al.  A Global Lab Against Influenza , 2001, Science.

[30]  Thorsten Wolff,et al.  Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade , 2001, Nature Cell Biology.

[31]  J. Taubenberger,et al.  The 1918 influenza virus: A killer comes into view. , 2000, Virology.

[32]  D. Grenier,et al.  The oral cavity as a reservoir of bacterial pathogens for focal infections. , 2000, Microbes and infection.

[33]  F. Scannapieco,et al.  Role of oral bacteria in respiratory infection. , 1999, Journal of periodontology.

[34]  R. Katz,et al.  Respiratory pathogen colonization of the dental plaque of institutionalized elders. , 1999, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[35]  R. Sidwell,et al.  Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection , 1998, Antimicrobial Agents and Chemotherapy.

[36]  K. Nakajima,et al.  Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase , 1993, Journal of virology.

[37]  R. Webster,et al.  Evolution and ecology of influenza A viruses. , 1992, Current topics in microbiology and immunology.

[38]  M. Kilian,et al.  Ecology of viridans streptococci in the oral cavity and pharynx. , 1991, Oral microbiology and immunology.

[39]  H. Klenk,et al.  Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. , 1987, Virology.

[40]  J. Mukaigawa,et al.  Inhibition of transcriptase activity of influenza A virus in vitro by anti-haemagglutinin antibodies. , 1985, Vaccine.

[41]  R. Compans,et al.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. , 1974, Virology.

[42]  M. Lüscher-mattli,et al.  Influenza chemotherapy: a review of the present state of art and of new drugs in development , 2014, Archives of Virology.

[43]  Thorsten Wolff,et al.  Interplay between influenza A virus and the innate immune signaling. , 2010, Microbes and infection.

[44]  Tanja Popovic,et al.  Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[45]  L. Shapira,et al.  Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function. , 2003, Nature immunology.

[46]  P. Kolenbrander,et al.  Oral microbial communities: biofilms, interactions, and genetic systems. , 2000, Annual review of microbiology.

[47]  R. Sidwell,et al.  Influenza virus resistance to neuraminidase inhibitors. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[48]  E. Newbrun,et al.  Neuraminidase activity in human dental plaque fluid. , 1979, Archives of oral biology.